The Discounted Cash Flow (DCF) valuation of Aspira Pathlab & Diagnostics Ltd (540788.BO) is 30.21 INR. With the latest stock price at 53.50 INR, the upside of Aspira Pathlab & Diagnostics Ltd based on DCF is -43.5%.
Based on the latest price of 53.50 INR and our DCF valuation, Aspira Pathlab & Diagnostics Ltd (540788.BO) is a sell. selling 540788.BO stocks now will result in a potential gain of 43.5%.
| Range | Selected | |
| WACC / Discount Rate | 10.2% - 12.1% | 11.2% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 24.73 - 39.08 | 30.21 |
| Upside | -53.8% - -27.0% | -43.5% |